Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, et al.
EBioMedicine (2021) Vol. 71, pp. 103561-103561
Open Access | Times Cited: 212
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Natalia Ortega, Marta Ribes, Marta Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 132
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 103, Iss. 1, pp. 115659-115659
Open Access | Times Cited: 73
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Gemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
EBioMedicine (2022) Vol. 75, pp. 103805-103805
Open Access | Times Cited: 67
Ambient Air Pollution in Relation to SARS-CoV-2 Infection, Antibody Response, and COVID-19 Disease: A Cohort Study in Catalonia, Spain (COVICAT Study)
Manolis Kogevinas, Gemma Castaño‐Vinyals, Marianna Karachaliou, et al.
Environmental Health Perspectives (2021) Vol. 129, Iss. 11
Open Access | Times Cited: 72
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile
Rocío Rubio, Ruth Aguilar, Mariona Bustamante, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China
Ying Xie, Yinghua Li, Zheng Su, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
Helena Linardou, Nikolaos Spanakis, Georgia-Angeliki Koliou, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4621-4621
Open Access | Times Cited: 37
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China
Xiaolong Yan, Xin Zhao, Yin Du, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107075-107075
Open Access | Times Cited: 4
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
Sergio Gil-Manso, Iria Miguéns Blanco, Rocío López-Esteban, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 19
Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
Raquel Guiomar, Ana João Santos, Aryse Martins Melo, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 154-154
Open Access | Times Cited: 16
The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 335-345
Open Access | Times Cited: 15
Sustained seropositivity up to 20.5 months after COVID-19
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Georgi K. Marinov, Младен Младенов, Antoni Rangachev, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274509-e0274509
Open Access | Times Cited: 13
Factors influencing the immune response over 15 months after SARS‐CoV‐2 infection: A longitudinal population‐wide study in the Faroe Islands
Maria Skaalum Petersen, Laura Pérez‐Alós, José Juan Almagro Armenteros, et al.
Journal of Internal Medicine (2022) Vol. 293, Iss. 1, pp. 63-81
Open Access | Times Cited: 12
Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project
Concepción Violán, Lucía A. Carrasco‐Ribelles, Giulia Collatuzzo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1340-1340
Open Access | Times Cited: 7
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature
Lorenzo Lo Muzio, Mariateresa Ambosino, Eleonora Lo Muzio, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 20, pp. 11001-11001
Open Access | Times Cited: 17
Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
Carlota Dobaño, Alfons Jiménez, Rocío Rubio, et al.
Translational research (2021) Vol. 240, pp. 26-32
Open Access | Times Cited: 15
COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response
Jenny Weinbrand-Goichberg, Efrat Ben Shalom, Choni Rinat, et al.
Journal of Nephrology (2021) Vol. 35, Iss. 1, pp. 121-129
Open Access | Times Cited: 12
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses
Emelie Marklund, Susannah Leach, Kristina Nyström, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain
Carlota Dobaño, Selena Alonso, Mariona Fernández de Sevilla, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Eleven‐month longitudinal study of antibodies in SARS‐CoV‐2 exposed and naïve primary health care workers upon COVID‐19 vaccination
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, et al.
Immunology (2022) Vol. 167, Iss. 4, pp. 528-543
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top